Letter to the Editor Regarding Long-Term Benefit–Risk Profiles of Treatments for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis

Detalles Bibliográficos
Autores principales: Pettitt, Dan, Plotnick, Michael, Gagne, Joshua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9674805/
https://www.ncbi.nlm.nih.gov/pubmed/36271223
http://dx.doi.org/10.1007/s13555-022-00809-8
_version_ 1784833229557071872
author Pettitt, Dan
Plotnick, Michael
Gagne, Joshua
author_facet Pettitt, Dan
Plotnick, Michael
Gagne, Joshua
author_sort Pettitt, Dan
collection PubMed
description
format Online
Article
Text
id pubmed-9674805
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-96748052022-11-20 Letter to the Editor Regarding Long-Term Benefit–Risk Profiles of Treatments for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis Pettitt, Dan Plotnick, Michael Gagne, Joshua Dermatol Ther (Heidelb) Letter Springer Healthcare 2022-10-21 /pmc/articles/PMC9674805/ /pubmed/36271223 http://dx.doi.org/10.1007/s13555-022-00809-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Letter
Pettitt, Dan
Plotnick, Michael
Gagne, Joshua
Letter to the Editor Regarding Long-Term Benefit–Risk Profiles of Treatments for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis
title Letter to the Editor Regarding Long-Term Benefit–Risk Profiles of Treatments for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis
title_full Letter to the Editor Regarding Long-Term Benefit–Risk Profiles of Treatments for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis
title_fullStr Letter to the Editor Regarding Long-Term Benefit–Risk Profiles of Treatments for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis
title_full_unstemmed Letter to the Editor Regarding Long-Term Benefit–Risk Profiles of Treatments for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis
title_short Letter to the Editor Regarding Long-Term Benefit–Risk Profiles of Treatments for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis
title_sort letter to the editor regarding long-term benefit–risk profiles of treatments for moderate-to-severe plaque psoriasis: a network meta-analysis
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9674805/
https://www.ncbi.nlm.nih.gov/pubmed/36271223
http://dx.doi.org/10.1007/s13555-022-00809-8
work_keys_str_mv AT pettittdan lettertotheeditorregardinglongtermbenefitriskprofilesoftreatmentsformoderatetosevereplaquepsoriasisanetworkmetaanalysis
AT plotnickmichael lettertotheeditorregardinglongtermbenefitriskprofilesoftreatmentsformoderatetosevereplaquepsoriasisanetworkmetaanalysis
AT gagnejoshua lettertotheeditorregardinglongtermbenefitriskprofilesoftreatmentsformoderatetosevereplaquepsoriasisanetworkmetaanalysis

Ejemplares similares